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Summary 
Recent data implicating loss of PTPIC tyrosine phosphatase activity in the genesis of the mul- 
tiple hemopoietic cell defects found in systemic autoimmune/immunodeficient motheaten (me) 
and viable motheaten (me  ~) mice suggest that PTP1C plays an important role in modulating 
intracellular signaling events regulating cell activation and differentiation.  To begin elucidating 
the role for this cytosolic phosphatase in lymphoid cell signal transduction, we have examined 
early signaling events and mitogenic responses induced by B cell antigen receptor (BCK) ligation 
in me and me ~ splenic B cells and in CD5 + CH12 lymphoma cells, which represent the lym- 
phoid population amplified in motheaten mice. Despite their lack of functional Irl'PlC, me and 
me  ~ B cells proliferated normally in response to LPS. However, compared with wild-type B cells, 
cells from the mutant mice were hyperresponsive to normally submitogenic concentrations  of 
F(ab')2 anti-Ig antibody,  and they exhibited  reduced susceptibility  to the inhibitory effects of 
Fc3'IIRB cross-linking on BCR-induced proliferation. Additional studies of unstimulated CH12 
and wild-type splenic B cells revealed the constitutive association of PTPIC with the resting 
BCR complex, as evidenced by coprecipitation of PTPIC protein and phosphatase activity with 
BCR components and the depletion of BCK-associated tyrosine phosphatase activity by anti- 
PTPIC antibodies. These results suggest a role for trl'PlC in regulating the tyrosine phosphory- 
lation state of the resting BCR complex components, a hypothesis supported by the observation 
that PTP1C  specifically induces dephosphorylation of a 35-kD BCR-associated  protein likely 
representing Ig-ot. In contrast, whereas membrane Ig cross-linking was associated with an in- 
crease in the tyrosine phosphorylation of PTP1C and an ,~140-kD coprecipitated protein, PTP1C 
was no longer detected in the BCR complex after receptor engagement, suggesting that PTP1C 
dissociates from the activated receptor complex.  Together  these results  suggest  a critical role 
for PTP1C in modulating BCR signaling capacity, and they indicate that the PTP1C influence 
on B cell signaling  is likely to be realized in both resting and activated cells. 
T 
he recent data linking the murine motheaten phenotype 
of severe systemic autoimmunity and immunodeficiency 
to loss-of-function mutations in the gene encoding the PTPIC 
tyrosine phosphatase  (1-3)  suggest  that this phosphotyro- 
1 Abbreviations used in this  paper: BCR, B cell antigen receptor; CHAPS, 
3-([3-cholamidopropyl]-dimethylammonio)-l-propane-sulfonate;  DTSP, 
dithiobis(succinimidyl  propionate);  Fcq41RB, B cell receptor for IgG Fc 
region; me, motheaten; me  v, viable motheaten; mlg, membrane lg; pNPP, 
p-nitrophenyl phosphate; PTK, protein tyrosine kinase; PTP, phosphotyro- 
sine phosphatase;  SH2,  src homology 2. 
sine phosphatase  (PTP) 1 plays a critical role in regulating 
hemopoietic cell differentiation  and function (1-3).  Since 
PTP1C is expressed in all hemopoietic cell types and contains 
two src homology 2 (SH2)  domains (4-6),  its  effects on 
hemopoiesis are likely realized through modulation of a mul- 
tiplicity of intracellular  signaling cascades. This hypothesis 
is supported  by the wide range of hemopoietic cell defects 
observed in mice homozygous for the motheaten (me) or al- 
lelic viable motheaten (me v)  mutations (7,  8),  animals in 
which PTP1C catalytic activity is negligible consequent  to 
production of no or mutant PTPIC protein, respectively (1). 
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naling pathways is also suggested by biochemical data showing 
association of this PTP with the c-kit,  Ib3, erythropoietin, 
and CSF-1 receptors (9-13).  Although the mechanisms by 
which PTP1C interacts with and modulates signals evoked 
by activation of these growth factor receptors have not been 
delineated, the massive overexpansion of myeloid, monocytic, 
and erythroid progenitor cells found in  me  and me V mice 
(14-16) suggests that PTP1C acts to down-regulate prolifer- 
ation and/or differentiation signals triggered by receptor en- 
gagement. 
In addition to engendering multiple myelomonocytic  cell 
abnormalities, loss of PTP1C function in me and me  v mice 
has a profound effect on B lymphoid ontogeny: the mutant 
mice show markedly increased numbers of peripheral B-1 or 
CD5 + B lymphocytes, a putatively autoreactive B cell sub- 
population that is normally concentrated in the peritoneal 
and pleural cavities (17-20).  The abnormal expansion of the 
CD5 + B cell population in me and me ~ mice and the asso- 
ciated high levels of serum Igs, autoantibodies, and B cell 
lymphokines in these mice again suggest a regulatory role 
for PTP1C in relation to induction of B cell activation, and 
raise the possibility that PTP1C normally functions to down- 
regulate signaling pathways coupling antigen and/or mitogen 
stimulation to proliferation. To investigate this possibility, 
we have examined the response  of PTPlC-deficient me and 
me  V B cells to B cell antigen receptor (BCR) engagement, 
and we have evaluated  PTP1C interactions with the BCR 
complex in the murine B cell lymphoma line CH12.  The 
data presented  here  reveal  an  increased  sensitivity of the 
motheaten B cells to proliferation signals  evoked by mem- 
brane Ig (mIg) llgation, and they indicate that PTP1C is phys- 
ically and functionally associated with the BCR complex in 
unstimulated B cells. By contrast, BCR engagement appears 
to disrupt PTP1C association with the antigen-receptor com- 
plex while inducing the tyrosine phosphorylation of both 
PTP1C and an associated  140-kD  molecule. Together these 
results demonstrate an important role for PTPIC in modu- 
lating signaling events coupling the BCR to cell activation. 
Materials and Methods 
Mice.  Mice  for these studies  were obtained  by mating C3HeBFeJ 
me/+  and +/+  and C57BL/6J  me  v and  +/+ breeding pairs de- 
rived from breeding stock maintained at the Samuel  Lunenfeld  Re- 
search Institute, Mount Sinai Hospital (Toronto, Canada). All mice 
used in the study were 3-5 wk old. 
Reagents.  Antibodies  used for these studies include a rat anti- 
Thyl.2 antibody purified from the hybridoma clone Jlj.10 (ATCC 
T1B184; American Type Culture Collection, Rockville, MD), a 
rabbit polyclonal anti-FTP1C SH2 domain antibody produced in 
our  lab  (1), rabbit  polyclonal anti-Syp  SH2  domain  and  an- 
tiphosphotyrosine antibodies provided by Dr. A. Pawson (Samuel 
Lunenfeld  Research Institute, Mount Sinai Hospital, Toronto, On- 
tario, Canada) (21), rabbit anti-MB-1 cytoplasmic tail antibody 
provided by Dr. L. Matsuuchi (Dept. of Zoology, University of 
British Columbia, Vancouver,  Canada) (22), rabbit anti-mouse Ig 
(# heavy chain; Serotec Ltd., Toronto, Ontario), affinity-purified 
F(ab')2 goat anti-mouse Ig (/~ heavy chain Cappel Laboratories, 
Durham,  NC),  and a murine IgM anti-CD5 antibody from the 
hybridoma line KT25 (Serotec  Ltd.). To derive  glutathione S-trans- 
ferase (GST)-FTP1C fusion protein for this work, the full-length 
PTP1C cDNA (1785 bp) was cloned into pGEX-2T (Pharmacia 
LKB Biotechnology Inc., Baie d'Urft, PQ) and transformed into 
Escherichia  coli JM101, and the fusion proteins were purified from 
bacterial tysates  after isopropyl  3-D-thiogalactopyranoside  induction. 
Cells  and  Cell  Lines.  The CD5 § murine B lymphoma line 
CH12 of 2'48 origin (23) (provided by D. A. Kaushik, Depts. of 
Veterinary  Microbiology and Immunology, University of Guelph, 
Guelph, Ontario) and the Thyl.2  § murine lymphoma line EL4 
(ATCC TIB39) were cultured in RPMI 1640 (Gibco Laboratories, 
Grand Island, NY) with 10% FCS (Sterile System Inc., Logan, 
UT), 50/~M 2-ME, 2 mM t-glutamine, and penicillinAtreptomycin 
and harvested in the log growth phase. Purified populations of 
mlg § splenic B lymphocytes were obtained from me,  me v,  and 
wild-type congenic (+/+ ) mice  by subjecting splenic cell suspen- 
sions to erythrocyte lysis in 0.8% ammonium chloride, followed 
by treatment with rat anti-Thyl.2 antibody for 30 min on ice and 
subsequent incubation with a 1:15 dilution of rabbit complement 
(Serotec Ltd.)  in  RPMI  1640 for  45  min  at  37~  The  T 
cell-depleted splenocytes  were then washed in Hepes-buffered sa- 
line and layered  on a 75/60/50%  Percoll gradient (Pharmacia), and 
high density  resting B lymphocytes  were recovered  from the 75/60% 
Percoll interface. The resulting ceils were >90%  mlg + as deter- 
mined by FACS  |  (Becton  Dickinson, Mountain View, CA) analysis. 
Proliferation  Assays.  Splenic  B cells were resuspended  in IMDM 
(Gibco Laboratories) containing 10% FCS, 50/zM 2-ME, 2 mM 
t-glutamine, antibiotics, and 100 U/ml II_,4 (Sigma Chemical Co., 
St. Louis, MO), and they were cultured in quadruplicate at a final 
concentration of 5 x  104 cells per 100/~1 in fiat-bottomed micro- 
titer plates in the presence or absence of varying concentrations 
of F(ab')2 goat anti-Ig antibody, 20/zg/ml intact rabbit anti-Ig an- 
tibody, or 20 #g/ml LPS (Sigma Chemical Co.). Cultures were 
continued for 48 h and pulsed with [3H]thymidine (1 /zCi per 
well) 6 h before terminating incubation. [3H]Thymidine  incorpo- 
ration was measured using an automated fl liquid scintillation 
counter. 
Cell Stimulation  and  Lysis.  CH12 cells (5  x  107) or purified 
splenic B cells (2  x  10  r) were resuspended in 5 ml of culture 
medium and stimulated with 25 #g/ml F(ab')2 anti-Ig antibody 
for varying periods of time (CH12 cells) or with 50/~g/ml anti-Ig 
antibody for 10 min (splenic B cells). Cells were stimulated  at 37~ 
washed in 9 ml of cold PBS with 1 mM sodium orthovanadate, 
and resuspended in 1 ml of lysis buffer (150 mM NaC1, 50 mM 
Tris-HC1, pH 8, 2 mM EDTA, 50 mM NaF, 1 mM PMSF, 1 mM 
sodium orthovanadate) containing either 5 mM 3-([3-cholamido- 
propyl]-dimethylammonio)-l-propane-sulfonate  (CHAPS) (Sigma 
Chemical Co.) or 1% NP-40 as detergents. Nuclei and unlysed  cells 
were removed by centrifugation at 4~  for 10 min at 14,000 g. 
For cross-linking studies, 5 x  107 CH12 cells were incubated for 
30 min with 20 #g/ml dithiobis(succinimidyl  propionate) (DTSP; 
Sigma Chemical Co.) in PBS at 4~  and washed twice in cold PBS 
plus NaN3 before lysis. 
Immunoprecipitation andlmmunoblotting.  Lysates  were precleared 
before immunoprecipitation by incubating 1 mg of cell lysate pro- 
tein in a volume of I ml with 40/zl of protein A-Sepharose beads 
(Pharmacia) for 1 h at 4~  and then with 40/zl of beads and 5 
/~1 of rabbit preimmune serum for an additional 1 h. Lysates  were 
then incubated for 2 h at 4~  with 5/xl of anti-PTP1C antibody, 
5 #1 of  intact anti-mouse Ig antibody, or 5/xl of rabbit preimmune 
serum and 10/~1 of protein A-Sepharose. Immunocomplexes  were 
collected by centrifugation (5 min at 10,000 g) and washed four 
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buffer. Samples were boiled for 5 min and electrophoresed through 
8% SDS-polyacrylamide gels, and the separated proteins were then 
transferred  to nitrocellulose  (Bio Rad Laboratories,  Mississauga, 
Ontario). Specific proteins were detected by immunoblotting with 
anti-PTPlC, anti-phosphotyrosine, or anti-MB-1 antibodies,  fol- 
lowed by incubation with ~2SI-protein A (Dupont-NEN, Boston, 
MA) in 10 mM Tris, pH 8.0,  150 mM NaCI, and 0.05% Tween 
20 and exposure to XAR film (Eastman  Kodak Co., Rochester, 
NY) at  -70°C. 
Assays  of Pkospkatase  Activity.  For analysis of BCR-associated 
phosphatase  activity,  anti-Ig immunoprecipitates were prepared 
as previously described from CHAPS lysates of I0  s unstimulated 
EL4 cells (control) or from 2.5,  5, or 10  x  107 CH12 cells in- 
cubated for 15 rain in medium alone, medium containing 50 #1 
mouse IgM (1:20 dilution of KT25 hybridoma supernatant), or 
medium containing 25 #g/ml F(ab')2 anti-Ig antibody. Phospha- 
tase assays  were also performed on anti-Ig immunoprecipitates pre- 
pared  from CHAPS  lysates  of 5  x  107  CH12  cells  immuno- 
depleted of PTP1C or Syp by overnight incubation with an excess 
(50/~1) of anti-PTPIC or anti-Syp antibodies, respectively, followed 
by addition of 100 #1 protein A-Sepharose.  Immunoprecipitates 
were washed three times in lysate buffer and then incubated at 37°C 
for 12 h in 200/~1 phosphatase  buffer (62 mM Hepes,  pH 5.0, 
6.25 mM EDTA, 12.5 mM DTT) containing 4 mM p-nitrophenyl 
phosphate (pNPP;  Sigma Chemical Co.). Reactions were termi- 
nated by addition of 0.8 ml of 200 mM NaOH, and absorbance 
was measured at 410 nm by spectrophotometry. For some experi- 
ments, reactions were performed in 40/~1 phosphatase buffer and 
terminated by addition of 0.16 ml of 200 raM NaOH; absorbance 
was measured  at 410 nm by ELISA. 
To assay PTP1C-induced  dephosphorylation of BCR-associated 
proteins, 5  x  107 unstimulated CH12 cells were suspended in lysis 
buffer with 1% digitonin, and the lysates were subjected to anti-Ig 
immunoprecipitation as previously described. Immunoprecipitates 
were washed three times in lysis buffer and once in kinase buffer 
(20 mM Hepes, NaOH, pH 7.4, 10 mM MgCI~), resuspended in 
25 #1 ofkinase buffer, and then incubated for 30 min at room tem- 
perature with 10 #Ci of [')'32-P]ATP (>3,000  Ci/mol; Amersham 
Corp., Arlington Heights, IL). The reaction was terminated by 
addition of I ml of cold phosphatase  buffer, and the precipitates 
were recovered by centrifugation and resuspended in 25/~1 phos- 
phatase buffer containing either 5/~g of the full-length GST-PTP1C 
fusion protein bound to Sepharose or Sepharose alone (control). 
After overnight incubation at 37°C, the reaction was stopped by 
addition of 25/xl of2x electrophoresis sample buffer, and the labeled 
proteins  were resolved by SDS-PAGE (8%  gel) and detected by 
autoradiography. 
Results and Discussion 
To investigate the potential relevance of PTPIC  activity 
to BCR-evoked activation, the effects of BCR cross-linking 
induced by anti-Ig antibody on lymphocyte proliferation were 
compared  in  me  and  me ~  PTPlC-deficient  and  wild-type 
congenic mice.  As measured by [3H]thymidine incorpora- 
tion, the maximal proliferative responses to F(ab')2  anti-Ig 
treatment were similar in magnitude in motheaten and con- 
trol cells (Fig. 1 A), and they were detected at the same time 
point after stimulation (48 h) in the wild-type and mutant 
cell cultures.  However,  as  indicated by the dose-response 
profiles shown in Fig. 1 A, peak proliferative responses oc- 
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Figure 1.  Effect  of anti-Ig and LPS on proliferation of me,  me  v, and 
normal splenic  B cel/s. (A) Splenic  B cells (5 x  104 per well) purified  from 
C3HeBFeJ  wild-type (O), me homozygous  (O), and C57B1/6J wild-type 
(V) or me  v heterozygous  (V) mice were cultured for 48 h with the indi- 
cated amounts of F(ab')2 goat anti-lg, and proliferation  was evaluated  after 
a 6-h pulse with [3H]thymidine.  (B) Splenic B cells purified  from me and 
rae  v homozygous,  and congenic  wild-type (+/+) mice were cultured for 
48 h in the presence of 15 ~g/ml F(ab')2 goat anti-Ig, 20/~g/ml intact 
rabbit anti-Ig, or medium alone, and they were pulsed with [3H]thymi- 
dine for the last 6 h of culture. (C) Splenic B cells purified from me  v 
homozygous  or C57B1/6J (+/+) mice were cultured for 48 h in the pres- 
ence of 20/~g/ml LPS and pulsed with [3H]thymidine for the last 6 h 
culture. Data are expressed as cpm, and values represent means (_+SEM) 
of quadruplicate cultures. 
curred in the mutant B cells at antibody concentrations 5-10 
times lower than those inducing peak responses in normal 
cells  (15  versus  150/~g/ml,  respectively).  Similarly, when 
stimulated with smaller amounts of anti-Ig (i.e., at concen- 
trations  <15  /~g/ml),  me  and  me v  B  cell  proliferative  re- 
sponses were consistently greater in magnitude than those 
observed in control mice. In contrast, at the anti-Ig dose range 
which stimulated maximal responses in normal B cells, the 
me  and me v  B cell proliferative responses were relatively re- 
duced. The increased responsiveness of the motheaten B cells 
relative to control cells was not a generalized phenomenon 
since proliferative responses to LPS were comparable in the 
mutant and wild-type splenic cells (Fig. 1 C). Moreover, the 
apparent shift in the anti-Ig dose-response profile observed 
in  me  and  me v  B  cells is unlikely to reflect differential ex- 
pression of mlg on motheaten versus control cells, as results 
of immunofluorescence analyses by our group (unpublished 
observations) and others (16, 24) have indicated levels ofmlgM 
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effect of mIg cross-linking on protein tyrosine phosphorylation in splenic 
B cells. Cell lysates were prepared from  2  x  107 unstimulated (-) or 
F(ab')2 anti-Ig (50/zg/ml)-stimulated  (+) normal splenic B cells. Cell ly- 
sates alone (L1/sate) or lysates immunoprecipitated with anti-PTPlC anti- 
body (Ip:PTP-IC) were subjected to SDS-PAGE,  transferred to nitrocellu- 
lose, and probed with anti-phosphotyrosine  antibody. The positions of 
PTPIC and a second  tyrosine-phosphoryhted protein are indicated  by arrows, 
and the mobilities of molecular mass standards are shown. 
to be, if anything, slightly lower on motheaten relative to 
normal B cells. Similarly,  the results cannot be ascribed to 
the presence of a largely CD5 + peripheral B cell population 
in  motheaten mice compared with  the predominance of 
CD5-  B cells in normal mice, as we (data not shown) and 
others (25) have found that in normal mice, the capacity of 
anti-Ig to elicit early activation events is substantially reduced 
in CD5 + compared with CD5-  B cells. Together these ob- 
servations suggest that the reduced threshold for anti-Ig-in- 
duced proliferation observed in motheaten B cells represents 
an abnormality specific to BCR-mediated signal transduc- 
tion and by extension imply a role for PTPIC in modulating 
signaling events coupling BCR engagement to proliferation. 
In contrast to the findings presented here, data from sev- 
eral earlier  studies suggested a severe reduction in me  and 
me v  B cell mitogenic responses (24, 26). These latter studies, 
however, involved analyses of whole splenic cell populations 
and the consequent exposure of the motheaten B cells to other 
hematopoietic cells affected by the mutation, most notably 
the expanded and putatively immunosuppressive  myelomono- 
cytic population (27,  28).  By contrast,  more recent data 
showing that phorbol ester responsiveness  is only slightly 
reduced in purified me ~ splenic B cells compared with CD5 + 
B cells from normal mice (29) indicate that motheaten B cells 
maintain the ability to proliferate in response to at least some 
mitogenic stimuli, and suggest that the defect responsible 
for increased  anti-Ig responses  in these cells acts at  a very 
proximal level, modifying  the signaling events associated with 
BCR engagement before activation of protein kinase C. This 
postulate is supported by the data shown in Fig.  1 B, which 
indicate that motheaten B cells are also distinguished from 
normal B cells by their proliferative responses to treatment 
with  intact  anti-Ig,  which in  contrast  to  F(ab')2 anti-Ig, 
co-cross-links mlg with the B cell Fc receptor,  Fc3,RIIB. 
Previous data concerning FcTRIIB involvement in B cell sig- 
naling have revealed that FcTIIB-mlg cross-linking suppresses 
Figure 3.  Association of PTPlC protein and phosphatase activity with 
the BCR. (A and B) Unstimulated CH12 calls (5  x  107) were lysed in 
5 mM CHAPS, 1% NP-40, or 1% NP-40 after pretreatment with 20/zg/ml 
DTSP. Lysates (1 mg protein) were immunoprecipitated with anti-Ig (A), 
anti-PTPlC (B), or rabbit preimmune serum (r.s.), and lysate (Lys) or im- 
munoprecipitated lysate proteins were analyzed by SDS-PAGE  and immu- 
noblotting with anti-PTPlC (A) or anti-Ig~x (/3) antibodies. The posi- 
tions of PTP1C, lg heavy chain (IgH), and Igcx are indicated by arrows, 
and the mobilities of size markers (in kilodaltons) are shown on the right. 
(Note:  lanes have been reorganized solely for clarity and to remove ex- 
traneous data and are from a single autoradiogram.) (C) Cell lysates were 
prepared from 10  s EL4 cells (lane 1 ), from 10  s (hnes 2 and 5), 5  x  107 
(lane 3), or 2.5  x  107 (lane 4) unstimulated CH12 cells, and from CH12 
cells pretreated with an excess of anti-Syp (lane 6) or anti-PTPlC (lane 
7) antibodies. Lysates  were immunoprecipitated  with anti-lg antibody or 
anti-Ig antibody plus an excess of mouse IgM (lane 5), and the precipi- 
tated proteins were incubated for 12 h with 4 nm pNPP at 37~  After 
addition of NaOH, absorbance was measured at 410 ran using an ELISA 
plate reader. The results are representative of five (lanes I-5) or two (lanes 
6 and 7) independent experiments. Bars indicate standard deviations for 
experiments performed in duplicate. 
early activation signals generated by BCR engagement, an 
effect  apparently  mediated through  interactions  between 
FcyRIIB and the Ig-cx and -/3 components of the BCR com- 
plex (30). As shown in Fig. 1 B, this phenomenon was also 
apparent in the wild-type cells studied here, which showed 
negligible proliferation after incubation with intact anti-Ig. 
By contrast, whereas the response of me  and me v  cells to in- 
tact  anti-Ig was also less than that induced by comparable 
amounts of F(ab')z anti-Ig,  the inhibitory effect of cross- 
linking Fc3,RII and mlg was much less striking in these cells 
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evidence for a role of PTPlC in modulating the molecular 
events relevant to propagation of the BCR-evoked prolifera- 
tion signal. 
To address further the involvement of FFPlC in BCR- 
driven mitogenesis, the possibility that this phosphatase, like 
many other cytoplasmic proteins implicated in mIg-mediated 
signaling (31, 32), undergoes tyrosine phosphorylation after 
receptor engagement was examined in anti-Ig-treated splenic 
B cells from normal mice. As determined  by antiphosphotyro- 
sine immunoblotting of total cell lysates, anti-Ig treatment 
induced marked increases in the tyrosine phosphorylation of 
a number of intracellular proteins (Fig. 2). However, although 
the amounts of Irl'PIC immunopredpitated  from resting and 
stimulated cells were comparable (data not shown), tyrosine 
phosphorylation of this 67-kD PTP was detected only in im- 
munoprecipitates  derived from anti-Ig-treated cells. Similarly, 
an ,o140-kD protein species coprecipitated with PTPlC was 
also tyrosine phosphorylated only after mIg ligation. Although 
its identity has not been determined, this latter phosphoprotein 
may represent CD22,  a BCR-associated adhesion molecule 
that has been reported to associate with PTPIC after BCR 
engagement (33). In any case, the induction of PTPlC tyro- 
sine phosphorylation after mlg ligation provides additional 
evidence for PTPlC involvement in the intracdlular signaling 
events elicited  by BCR engagement. 
These initial observations implicating PTPlC in BCR- 
mediated signal transduction raised the possibility that PTPlC 
might physically associate with proteins making up the BCR 
complex. To determine whether PTPlC interacts with the 
BCR constituents, i.e., mlg and the associated Ig-ot (MB-1) 
and Ig-B (B29) heterodimer, the presence of PTPlC was evalu- 
ated in anti-Ig immunoprecipitates  prepared from CH12 cells, 
a  murine  B  lymphoma  phenotypically  similar  (CD5 +, 
IgM  hi, IgD  l~  to me and me  v B cells (23). As shown in Fig. 
3 A,  FFPlC was detectable in anti-Ig immunoprecipitates 
from CHAPS lysates of unstimulated CH12 cells. As is con- 
sistent with previous data showing disruption of the BCR 
complex components by harsh detergents (34), less PTPlC 
protein was detected in anti-Ig immunoprecipitates from CH12 
lysates prepared with NP-40, whereas copredpitation  of PTP1C 
with mIg was increased when NP-40 lysates were prepared 
from cells pretreated with DTSP, a chemical cross-linker pre- 
viously shown to  stabilize  the  mIg/IgodB  complex (35). 
PTP1C interaction with mIg is not restricted to CH12 cells 
since association of these proteins was also observed in un- 
stimulated fresh splenic B cells and in the CD5-  WEHI- 
231  lymphoma ceils (data  not  shown).  Moreover,  in  the 
reciprocal experiment, mIg was also detected in anti-PTPlC 
immunoprecipitates from the CH12 cells (data not shown). 
Similar results were also observed with respect to Igcz, which 
coprecipitated more ef~ciently with PTP1C from CHAPS 
and NP-40/DTSP than from NP-40 lysates of CH12 cells (Fig. 
3 B). These observations suggest that trFPlC binds to the 
unstimulated BCR, either directly,  by association  with the 
Ig-odj3 heterodimer, or indirectly, by interaction with other 
molecules associated with the resting receptor complex, such 
as  the protein tyrosine kinases  (PTK),  lyn,  fyn,  and blk 
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Figure  4.  In vitro tyrosine dephosphory- 
lation of BCR-associated proteins by GST- 
trI'PIC fusion protein.  Lysates from 5  x  10  ~ 
unstimulated CH12 cells were immunopre- 
cipitated  with  anti-Ig  antibody,  and  the 
immunoprecipitated proteins were tyrosine 
phosphorylated in vitro (see Materials  and 
Methods) and incubated with 5/zg Sepharose- 
bound GST-PTP1C (+) or Sepharose alone 
(-). Immunoprecipitated proteins were sub- 
jected to SDS-PAGE, and phosphorylation 
was visualized by autoradiography. The arrow 
indicates the position of an "~35-kD species 
apparently selectively tyrosine dephosphor- 
ylated after incubation with GST-PTP1C. 
(36-38),  all of which have been reported to bind to Iga in 
unstimulated B cells (39). Although both the Igoe/3 subunits 
contain several tyrosine phosphorylation sites that represent 
potential targets for SH2 domain-mediated protein binding, 
the association of FTP1C with the receptor complex occurs 
in resting cells, in which these components are phosphorylated 
at only low levels (21). This observation, in conjunction with 
the relative instability of the PTPIC mlg/Igo~ association in 
NP-40,  suggests that PTP1C binding to the resting BCR 
is not mediated through the interaction of PTP1C SH2 do- 
mains with phosphotyrosine. 
To determine whether the PTP1C protein associated with 
the unstimulated BCR complex is enzymatically active, anti-Ig 
immunoprecipitates from CH12 cells were evaluated for the 
presence of tyrosine phosphatase activity.  As shown in Fig. 
3 C, these immunoprecipitates displayed a cell dose-depen- 
dent capacity to dephosphorylate pNPP substrate,  a finding 
that suggests the coprecipitation of a catalytically active phos- 
phatase.  To assess the extent to which PTP1C accounts for 
anti-Ig immunoprecipitable  phosphatase activity, this experi- 
ment was  also performed on lysates from CH12 cells im- 
munodepleted  of either PTP1C or the structurally similar tyro- 
sine phosphatase Syp (21). Results from this analysis revealed 
BCR-associated phosphatase activity to be unaffected by Syp 
immunodepletion,  but markedly reduced in PTPlC-immuno- 
depleted samples (Fig. 3 C). Although these data do not pre- 
clude the contribution of PTPs other than PTP1C to the tyro- 
sine phosphatase activity detected in BCR immunoprecipitates, 
the findings suggest that PTPIC accounts for a significant 
proportion of this activity and as such may act to suppress 
or minimize tyrosine phosphorylation of the Igcr  subunits 
or other BCR-associated proteins in resting cells. To pursue 
this issue, anti-Ig immunoprecipitable proteins from resting 
CH12 cells were tyrosine phosphorylated in vitro and in- 
cubated with GST-PTPIC fusion protein. As shown in Fig. 
4,  PTP1C specifically dephosphorylated at least  one mlg- 
associated protein of ,o35 kD, which may represent Igc~. Al- 
though the physiologic relevance of this observation is un- 
clear, the data indicate that Igoe may represent a substrate 
for PTPIC activity in resting B cells and that PTPIC may 
therefore serve to counteract effects of PTK activity on the 
receptor components, thereby maintaining the BCR in a de- 
phosphorylated state. Filgna~ 5.  Effect  of  cross-linking  mlg on 
PTP1C association  with the BCR. (.4) At 
the indicated times after addition of 25 
/xg/ml anti-Ig antibody, lysates  prepared 
from 5 ￿  107 CH12 cells were immuno- 
precipitated  with anti-Ig  antibody  or rabbit 
preimmune  serum  (r.s.), and the lysate  (Lys) 
or immunoprecipitated  lysate  proteins  were 
resolved by SDS-PAGE and immunoblot- 
ring  with  anti-PTIrlC  antibody.  The migra- 
tion of  PTP1Cjust above  the Ig heavy  chain 
is shown  by the arrow  on the left.  (/3) 20-/A 
aliquots of the same  lysates  used  in experi- 
ment A were analyzed  by SDS-PAGE and 
immunoblotting with anti-phospbotyro- 
sine antibody. (C) Lysates  were prepared 
from 5 x 107 CH12 cells incubated  for 15 
rain at 37"C  with (lane  a) or without  (lane 
b) 25/zg/ml  anti-Ig  antibody,  or with  rabbit 
preimmune serum (lane C). Lysates  were 
subjected to anti-lg immunoprecipitation 
and the precipitated  proteins  were  incubated 
for 12 h at 37~  with 4 mM pNPP. After 
addition of NaOH, absorbance  was mea- 
sured spectropbotometrically  at 410 nM. 
The data  shown  are representative  of three 
independent experiments. 
To investigate further the influence of PTP1C on BCR sig- 
naling capacity, we next examined the effect of anti-Ig stim- 
ulation on association  between PTP1C and the BCK com- 
plex.  As indicated by anti-PTP1C immunoblot analysis of 
anti-Ig-immunoprecipitates from anti-Ig treated CH12 cells, 
BCK engagement induced a rapid dissociation of the PTP1C- 
BCR  complex:  PTP1C  was  nondetectable  in  the  im- 
munoprecipitates by 30 s after cell stimulation (Fig.  5 A). 
As is consistent with dissociation of PTPIC from the acti- 
vated receptor complex, anti-Ig-immunoprecipitable phos- 
phatase activity was also appreciably  diminished at 15 min 
after receptor engagement (Fig. 5 C). These results cannot 
be ascribed to impaired solubilization of the activated receptor 
complex or failure to induce receptor activation, as the amounts 
of Igor immunoprecipitated under the same conditions were 
essentially the same in resting and activated B cells (data not 
shown), and anti-Ig induction of intracellular protein tyro- 
sine phosphorylation was observed  in aliquots of the same 
cell lysates used to examine PTP1C-BCR complex associa- 
tion (Fig. 5 B). Interestingly, whereas levels of tyrosine phos- 
phorylation appeared to peak at about 15 min after receptor 
stimulation and decline  thereafter, PTP1C association with 
the BCR remained undetectable 15 min after stimulation, 
and reassociation  was first detected only at 30 min after acti- 
vation. Whether this finding indicates a negative influence 
of tyrosine phosphorylation on the interaction between PTP1C 
and  the  receptor  components  remains  to  be  determined. 
Regardless  of the mechanism, the rapid disruption of the 
PTP1C interaction with the BCK complex after receptor ac- 
tivation, as revealed by the data shown here, provides a means 
to remove the putatively negative influence of  PTP1C on BCK 
tyrosine phosphorylation and signal amplification. Delayed 
reassociation  of PTPIC with the receptor complex may in 
turn facilitate  termination of the activation signal, thereby 
contributing to the transient nature of early activation events 
in B cells. 
The observed association between lack of FTPIC function 
and increased sensitivity of the BCR to ligand-binding prolifer- 
ation signals,  together with the demonstrated capacity of 
PTP1C to physically bind and to potentially dephosphory- 
late components of the antigen-receptor complex in unstimu- 
lated B cells, identifies  PTP1C as an important effector in 
the modulation of BCR signaling function. The demonstra- 
tion that this phosphatase  associates with the resting receptor 
complex implies that FTP1C effects on BCR signal propaga- 
tion are realized,  at least in part, at the level of the receptor 
complex and may reflect the capacity of this phosphatase to 
counteract  FTK-induced  tyrosine phosphorylation of the 
receptor and/or associated signaling molecules. This conten- 
tion is consistent with data showing that FTKs associate with 
the resting receptor complex (36-38) and may therefore tyro- 
sine  phosphorylate receptor  subunits,  albeit at  low levels, 
thereby potentially rendering the receptor refractory to fu- 
ture stimulation. Thus, in contrast to the BCR-associated 
PTKs that promote receptor signaling largely by virtue of 
their  activation  after  BCK  stimulation,  the  influence  of 
2082  A Role for PTP1C Tyrosine  Phosphatase  in B Cell Signaling PTPIC,  at least on BCR components per se, may be prin- 
cipally an inhibitory effect realized before receptor engage- 
ment.  A  similar role has also been ascribed to the receptor 
tyrosine phosphatase CD45 (40). However, since direct physical 
association of CD45 with the resting BCR complex has not 
been reported and PTPIC immunodepletion from anti-Ig im- 
munoprecipitates essentially abrogates BCR-associated phos- 
phatase activity, it appears likely that maintenance  of a tyrosine- 
dephosphorylated receptor complex in resting cells is achieved 
largely through  PTPIC  activity. 
Although receptor engagement appears to result in phys- 
ical dissociation of PTP1C from the BCK complex, the cur- 
rent as well as other reported data (30) suggest that mlg li- 
gation is followed by IrFPIC binding to several other proteins 
implicated in BCR-mediated signaling, specifically the trans- 
membrane  molecules CD22  and  Fcq,  KIIB,  which become 
tyrosine phosphorylated after cross-linking of mlg or mlg- 
Fc'yRIIB, respectively (30, 33). In contrast to PTP1C asso- 
ciation  with  the resting  BCR,  its  binding  to  these latter 
proteins appears to be mediated through  its SH2 domains 
(reference 33 and unpublished data).  By analogy, whereas cou- 
pling of PTKs such as fyn and lyn to the stimulated BCR 
Igot/~ heterodimer is mediated primarily through PTK SH2 
domain binding to IgodB phosphotyrosine (39), the associa- 
tion of these molecules in resting cells does not appear to 
involve SH2-phosphotyrosine interactions (39). In a similar 
fashion,  PTP1C  displaced  from  the  BCR  complex  after 
receptor engagement may be recruited via its SH2 domains 
to associations with other transmembrane  or more down- 
stream cytoplasmic signaling effector molecules and thereby 
influence BCR signaling capacity via several distinct molec- 
ular interactions.  Although the molecular basis for such in- 
teractions requires further definition,  it appears likely that 
PTP1C exerts a predominantly negative influence on signal 
propagation through the BCR. This putative inhibitory in- 
fluence of PTP1C on receptor-driven B cell mitogenesis is 
consistent with the phenotype of B cell hyperactivity observed 
in motheaten mice, as well as the tendency of me  v heterozy- 
gous animals  to develop B cell lymphomas over time, pos- 
sibly consequent  to  functional  inactivation  of the  normal 
PTP1C allele (16). Therefore, though further studies are re- 
quired  to elucidate fully the  effects of PTP1C  on antigen 
receptor-directed signaling in conventional as well as CD5 + 
B-1 cells and the mechanisms by which abrogated PTP1C 
function translates to overexpansion of the normally minor 
B-1 population, the data presented here provide compelling 
evidence of a critical role for PTP1C in the regulation of B 
cell signaling. 
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